Full Programme is available here.
Click on title to download PDF:
1. Treatment of IgA nephropathy: Update after KDIGO guidelines
Prof. Philip K.T. Li (President of APSN / CUHK Carol & Richard Yu PD Research Centre / Prince of Wales Hospital / Chinese University of Hong Kong, Hong Kong)
2. FGF-23 and vascular calcification in CKD: is it set in stone?
Prof. Sydney Tang (Division of Nephrology, Department of Medicine, The University of Hong Kong, Hong Kong)
3. The recent Issues on kidney disease and dialysis therapy in the kingdom of Bhutan
Prof. Tatsuo Tsukamoto (Division of Nephrology and Dialysis, Kitano Hospital, The Tazuke Kofukai Medical Research Institute, Osaka, Japan)
4. Peritoneal dialysis – variability in teaching leading to variable outcomes?
Prof. Matthew Jose (School of Medicine at the University of Tasmania / Menzies Institute for Medical Research and a Renal Physician at the Royal Hobart Hospital, Tasmania, Australia)
5-1. Lecture: Secondary hypertension: -The Kidney as an Endocrine Target Organ give you a clue to the diagnosis of Secondary hypertension
Prof. Masataka Kudo (Division of Nephrology, Endocrinology and Vascular Medicine, Department of Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan)
5-2. Renal impairment in primary aldosteronism; case series
Prof. Ryo Morimoto (Division of Nephrology, Endocrinology and Vascular Medicine, Department of Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan)
6. CKD of uncertain aetiology
Prof. David Harris (President of ISN / Ex-president of APSN / Westmead Hospital and University of Sydney, Sydney, Australia)
7. The pathophysiology of AKI
Prof. Rob Walker (Department of Medicine, Dunedin School of Medicine, University of Otago / Southern District Health Board, New Zealand)
8-1. Early complications after kidney transplantation: current screening, diagnosis and treatment
Prof. Kosuke Masutani (Division of Nephrology and Rheumatology, Department of Internal Medicine, Fukuoka University, Fukuoka, Japan)
8-2. BK viral infection and malignancy in renal transplantation: case based discussion
Prof. Mariko Toyoda (Kumamoto Red Cross Hospital, Kumamoto, Japan)